Self-reported reactogenicity of RSV vaccines among older adults: a post-licensure study within a large integrated healthcare system in Southern California
The most common reactions after RSV vaccines were local pain, fatigue, myalgia, and headache. GSK vaccine recipients containing the AS01E adjuvant reported reactions more frequently than Pfizer vaccine recipients. Consistent with pre-licensure safety data, most symptoms were transient and did not require medical care.
Authors
- Bradley K. Ackerson (ORCID: https://orcid.org/0000-0002-0816-7345)
- Sungching Glenn (ORCID: https://orcid.org/0000-0002-0041-0996)
- Denison S Ryan (ORCID: https://orcid.org/0000-0001-8440-3859)
- Sara Y. Tartof (ORCID: https://orcid.org/0000-0003-2336-8476)
- Eric Weintraub (ORCID: https://orcid.org/0000-0003-0375-0504)
- Julianne Gee (ORCID: https://orcid.org/0000-0003-4244-8068)
- Debbie Malden
- Michael M. McNeil
- Zhuoxin Li
- Amelia Jazwa
- Sunhea Kim
- Marisa A. Peryer
Institutions
- Centers for Disease Control and Prevention (US)
- Kaiser Permanente (US)
- National Center for Immunization and Respiratory Diseases (US)
Publication Details
- Journal
- Vaccine
- Published
- 2026-03-23
- DOI
- https://doi.org/10.1016/j.vaccine.2026.128493
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00